ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

CORT Corcept Therapeutics Inc

26,90
3,58 (15,35%)
01 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Corcept Therapeutics Inc CORT NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
3,58 15,35% 26,90 20:57:49
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
23,09 22,60 24,61 23,88 23,32
mais cotações »

Notícias Recentes

Data Hora Fonte Título
01/05/202417:05GLOBECorcept Therapeutics Announces First Quarter Financial..
29/04/202409:00GLOBECorcept Completes Enrollment in Phase 4 CATALYST Trial
24/04/202417:05GLOBECorcept Therapeutics to Announce First Quarter Financial..
22/04/202409:00GLOBECorcept Announces Positive Results From Open-Label Portion..
15/04/202409:00GLOBECorcept Completes Enrollment in Phase 2 DAZALS Trial in..
08/04/202409:00GLOBECorcept Completes Enrollment in Pivotal Phase 3 Rosella..
01/04/202409:00GLOBECorcept Completes Enrollment in Phase 3 Gradient Trial of..
15/02/202418:07GLOBECorcept Therapeutics Announces Fourth Quarter and Full-Year..
15/02/202418:02GLOBECorcept Announces Preliminary Results From Prevalence Phase..
08/02/202418:05GLOBECorcept Therapeutics to Announce Fourth Quarter and..
29/01/202410:00GLOBECorcept Appoints Roberto Vieira as President, Oncology
08/01/202410:00GLOBECorcept Therapeutics Provides Financial Update and Announces..
02/01/202410:00GLOBECourt Finds Corcept Therapeutics’ Patents Not Infringed
01/11/202317:05GLOBECorcept Therapeutics Announces Third Quarter Financial..
01/11/202309:00GLOBECorcept Appoints Monica Tellado as President, Emerging..
26/10/202317:05GLOBECorcept Initiates MONARCH – A Phase 2b Trial in..
25/10/202317:05GLOBECorcept Therapeutics to Announce Third Quarter Financial..
02/08/202317:05GLOBECorcept Therapeutics Announces Second Quarter Financial..
26/07/202317:05GLOBECorcept Therapeutics to Announce Second Quarter Financial..
17/07/202317:05GLOBECorcept’s Miricorilant Shows Great Promise in Treatment of..
27/06/202309:00GLOBEJournal of Clinical Oncology Publishes Results of Corcept’s..
03/05/202317:05GLOBECorcept Therapeutics Announces First Quarter Financial..

Seu Histórico Recente

Delayed Upgrade Clock